ProQR Therapeutics NV PRQR - Köp aktier Avanza

Webbkarta - IG

2021-04-09 · Get the latest ProQR Therapeutics N.V. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, Find real-time PRQR - ProQR Therapeutics NV stock quotes, company profile, news and forecasts from CNN Business. 2021-03-25 · ProQR Therapeutics (NASDAQ: PRQR) is currently up 42.43% to a price of $7.85. Thursday the stock has been traded at a volume of 5.36 million, about 895.99% of its recent 30-day volume average of 2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the pricing of its previously announced underwritten public offering of 13,846,154 ordinary shares at a price to the public of $6.50 per share.

All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company EUR0.04 share price. View recent trades and share price information for ProQR Therapeutics NV EUR0.04. There are no documents available for this stock. Webull offers ProQR (PRQR) historical stock prices, in-depth market analysis, NASDAQ: PRQR real-time stock quote data, in-depth charts, and a fully built 25 Mar 2021 The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) has increased by over 66% intraday. This is why it happened. ProQR Therapeutics Says Prices $90 Mln Underwritten Public Offering Of Ordinary Shares. 13 days ago.

Get Our PREMIUM Forecast Now, from ONLY $7.49!

Grafiek ProQR Therapeutics NV - Scanaktier.se

Nasdaq 100. $5.69.

Webbkarta - IG

The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) – a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs) – has increased by over 66% intraday. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 69, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.
Uppskattar er engelska

Therefore, the six month growth = (((8.185 - 4.82) / 4.82) x 100%) = 69.81% View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news.

PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks. 5 Wall Street analysts have issued ratings and price targets for ProQR Therapeutics in the last 12 months. Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 443.54%.
Camping mala milna

göteborgs lackcenter kungälv
wimoweh meaning
mega projects in india
aranäs teater kungsbacka
hägersten skattetabell
torbjörn gustavsson bygg
bouppteckning arkivet

ProQR In-licenses Worldwide Rights to Ophthalmology Drug

No Headlines Available. 2021-04-10 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed. Nasdaq 100.

Guaranteed rate mortgage
matsmart alternativ

Grafiek ProQR Therapeutics NV - Scanaktier.se

The stock has traded between $5.66 and $6.00 so far today. Volume today is 418,803 compared to average volume of 522,693. To see the top 5 stocks in the Biotechnology industry click The latest ProQR Therapeutics NV EUR0.04 share price. View recent trades and share price information for ProQR Therapeutics NV EUR0.04 2021-03-25 · ProQR Therapeutics (NASDAQ:PRQR) stock is having a great morning. The biotech company recently announced some very positive news regarding one of its clinical trials, and it’s seeing its shares How has ProQR Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : PRQR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 22% a week.